Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202507738515354Phase 3Not yet recruiting
Phase 3, open-label trial of fentanyl and ropivacaine in Cardiovascular Malformation (CVM) and postoperative pain (2 arms), sponsored by ghada medhat. Primary endpoint: Time to extubation. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202507738515354.